HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a small D-enantiomeric Alzheimer's amyloid-β binding peptide ligand for future in vivo imaging applications.

Abstract
Alzheimer's disease (AD) is a devastating disease affecting predominantly the aging population. One of the characteristic pathological hallmarks of AD are neuritic plaques, consisting of amyloidpeptide (Aβ). While there has been some advancement in diagnostic classification of AD patients according to their clinical severity, no fully reliable method for pre-symptomatic diagnosis of AD is available. To enable such early diagnosis, which will allow the initiation of treatments early in the disease progress, neuroimaging tools are under development, making use of Aβ-binding ligands that can visualize amyloid plaques in the living brain. Here we investigate the properties of a newly designed series of D-enantiomeric peptides which are derivatives of ACI-80, formerly called D1, which was developed to specifically bind aggregated Aβ1-42. We describe ACI-80 derivatives with increased stability and Aβ binding properties, which were characterized using surface plasmon resonance and enzyme-linked immunosorbent assays. The specific interactions of the lead compounds with amyloid plaques were validated by ex vivo immunochemistry in transgenic mouse models of AD. The novel compounds showed increased binding affinity and are promising candidates for further development into in vivo imaging compounds.
AuthorsSusanne Aileen Funke, Dirk Bartnik, Julian Marius Glück, Kasia Piorkowska, Katja Wiesehan, Urs Weber, Balazs Gulyas, Christer Halldin, Andrea Pfeifer, Christian Spenger, Andreas Muhs, Dieter Willbold
JournalPloS one (PLoS One) Vol. 7 Issue 7 Pg. e41457 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22848501 (Publication Type: Journal Article)
Chemical References
  • Amyloid
  • Amyloid beta-Peptides
  • D1 peptide
  • Ligands
  • Oligopeptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)
Topics
  • Alzheimer Disease (diagnosis, metabolism)
  • Amyloid (chemistry, metabolism)
  • Amyloid beta-Peptides (chemistry, metabolism)
  • Animals
  • Diagnostic Imaging (methods)
  • Ligands
  • Mice
  • Neurites (metabolism, pathology)
  • Oligopeptides (chemistry, metabolism)
  • Peptide Fragments (chemistry, metabolism)
  • Protein Binding

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: